“An exploratory Integrated Moving Average Time Series Model of the initial outbreak of COVID-19 in six (6) significantly impacted Countries”

Footnotes

• Additional Information

  Question: Response

• Financial Disclosure

  NO

  Enter a financial disclosure statement that describes the sources of funding for the work included in this submission. Review the submission guidelines for detailed requirements. View published research articles from PLOS ONE for specific examples.

  This statement is required for submission and will appear in the published article if the submission is accepted. Please make sure it is accurate.

• Unfunded studies

  Enter: The author(s) received no specific funding for this work.

• Funded studies

  Enter a statement with the following details:

  • Initials of the authors who received each award

  • Grant numbers awarded to each author

  • The full name of each funder

  • URL of each funder website

  • Did the sponsors or funders play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript?

  • NO - Include this sentence at the end of your statement: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

  • YES - Specify the role(s) played.

    * typeset

• Competing Interests

  NO

  Use the instructions below to enter a competing interest statement for this submission. On behalf of all authors, disclose any competing interests that could be perceived to bias this work—acknowledging all financial support and any other relevant financial or non- financial competing interests.

  This statement will appear in the published article if the submission is accepted. Please make sure it is accurate. View published research articles from PLOS ONE for specific examples.

• NO authors have competing interests

  Enter: The authors have declared that no competing interests exist.

• Authors with competing interests

  Enter competing interest details beginning with this statement:

  I have read the journal’s policy and the authors of this manuscript have the following competing interests: [insert competing interests here]

  * typeset

• Ethics Statement

  N/A

  Enter an ethics statement for this submission. This statement is required if the study involved:

  • Human participants

  • Human specimens or tissue

  • Vertebrate animals or cephalopods

  • Vertebrate embryos or tissues

  • Field research

  Write “N/A” if the submission does not require an ethics statement.

  General guidance is provided below. Consult the submission guidelines for detailed instructions. Make sure that all information entered here is included in the Methods section of the manuscript.

• Format for specific study types

  Human Subject Research (involving human participants and/or tissue)

  • Give the name of the institutional review board or ethics committee that approved the study

  • Include the approval number and/or a statement indicating approval of this research

  • Indicate the form of consent obtained (written/oral) or the reason that consent was not obtained (e.g. the data were analyzed anonymously)

• Animal Research (involving vertebrate animals, embryos or tissues)

  • Provide the name of the Institutional Animal Care and Use Committee (IACUC) or other relevant ethics board that reviewed the study protocol, and indicate whether they approved this research or granted a formal waiver of ethical approval

  • Include an approval number if one was obtained

  • If the study involved non-human primates, add additional details about animal welfare and steps taken to ameliorate suffering

  • If anesthesia, euthanasia, or any kind of animal sacrifice is part of the study, include briefly which substances and/or methods were applied

• Field Research

  Include the following details if this study involves the collection of plant, animal, or other materials from a natural setting:

  • Field permit number

  • Name of the institution or relevant body that granted permission

• Data Availability

  Yes - all data are fully available without restriction

  Authors are required to make all data underlying the findings described fully available, without restriction, and from the time of publication. PLOS allows rare exceptions to address legal and ethical concerns. See the PLOS Data Policy and FAQ for detailed information.

  A Data Availability Statement describing where the data can be found is required at submission. Your answers to this question constitute the Data Availability Statement and will be published in the article, if accepted.

• Important

  Stating ‘data available on request from the author’ is not sufficient. If your data are only available upon request, select ‘No’ for the first question and explain your exceptional situation in the text box.

  Do the authors confirm that all data underlying the findings described in their manuscript are fully available without restriction?

  Describe where the data may be found in full sentences. If you are copying our sample text, replace any instances of XXX with the appropriate details.

  Data is located in first author’s Drive in an Excel file and available upon request.

  • If the data are held or will be held in a public repository, include URLs, accession numbers or DOIs. If this information will only be available after acceptance, indicate this by ticking the box below. For example: All XXX files are available from the XXX database (accession number(s) XXX, XXX.).

  • If the data are all contained within the manuscript and/or Supporting Information files, enter the following: All relevant data are within the manuscript and its Supporting Information files.

  • If neither of these applies but you are able to provide details of access elsewhere, with or without limitations, please do so. For example:

  Data cannot be shared publicly because of [XXX]. Data are available from the XXX Institutional Data Access / Ethics Committee (contact via XXX) for researchers who meet the criteria for access to confidential data.

  The data underlying the results presented in the study are available from (include the name of the third party and contact information or URL).

  • This text is appropriate if the data are owned by a third party and authors do not have permission to share the data.

  * typeset

  Additional data availability information: